Patents Assigned to Alchemab Therapeutics Ltd
  • Publication number: 20240203523
    Abstract: Methods of identifying an antigen-binding protein comprising a pair of chains are described. The methods comprise providing a query sequence comprising a first chain sequence, and identifying a corresponding chain sequence by providing the query sequence to a deep learning model configured to take as input a query first chain sequence and to produce as output at least one corresponding chain sequence, thereby identifying a corresponding chain sequence for the query sequence, wherein the deep learning model has been trained using training first and corresponding chain sequences from known chain pairs. The first chain sequence may be a heavy/light chain of an antibody or B cell receptor or ?/?/?/? chain of a T cell receptor, and the corresponding chain may be a light/heavy chain of an antibody or B cell receptor or an a ?/?/?/? chain of a T cell receptor. The methods find uses in any context where it is desirable to identify chain pairings for antigen-binding molecules, such as e.g.
    Type: Application
    Filed: April 14, 2022
    Publication date: June 20, 2024
    Applicant: Alchemab Therapeutics Ltd
    Inventors: Jinwoo Leem, Jacob Galson
  • Publication number: 20230192821
    Abstract: There is provided inter alia a polypeptide comprising a CDRH1 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH1 sequence as shown in Table 1 and/or a CDRH2 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH2 sequence as shown in Table 1 and/or a CDRH3 sequence comprising or consisting of a sequence sharing 80% or greater sequence identity with a CDRH3 sequence as shown in Table 1.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 22, 2023
    Applicants: Alchemab Therapeutics Ltd, BARTS HEALTH NHS TRUST
    Inventors: Jane Osbourn, Ralph Minter, Jacob Galson